Could TRIPS save lives in Third World Countries by opening research articles?

That is one very interesting idea! This provision is usually used for getting medicines to 3rd world countries in times of emergency. So, why not research papers if the emergency warrants it? Gavin writes:

Imagine a scenario in which a developing country is facing a national health emergency, and there's a research article that contains information that is highly relevant to addressing that emergency. Let's say the emergency is an alarmingly high rate of mother-to-child transmission of HIV, and a new study shows a major breakthrough in preventing such transmission. And let's say that unfortunately the article copyright is owned by the publisher (not the author), and the article is locked away behind a typical subscription barrier (usually around $30 per person to view it).

Could the government, asked Shahram, invoke TRIPs [The Agreement on Trade Related Aspects of Intellectual Property Rights] to simply bypass the copyright holder and disseminate the article across the nation?

Tell Gavin what you think.

More like this

I've spent some time here (old site, here, here, here, here and here) explaining WHO's place in the international system. It explains certain things I thought important to understand. An important part of the international "system" (Westphalian-style) is there is no official authority over…
Despite the fact that the radically religious and conservative politicians like to focus on homosexual males and IV drug use leading to HIV-1 infection, the fact of the matter is, heterosexual women are the fastest growing group of HIV-1 patients in the US (and Africa, and Asia)-- even women in…
I'm committed to a lot of different kinds of "open." This means that I can and do engage in tremendous acts of hair-splitting and pilpul with regard to them. "Gratis" versus "libre" open access? Free-speech versus free-beer software code? I'm your librarian; let's sit down and have that discussion…
Last year, I taught a short course at Gilead Sciences in California and was impressed by not only the high quality of their scientific research but their efforts to increase access of their HIV medications to developing countries. Now Gilead has joined a group of pharmaceutical companies to try…